Company Announcements

Board Changes

Source: RNS
RNS Number : 2051G
Burberry Group PLC
23 November 2020





Burberry Group plc (the "Company") is pleased to announce that Antoine Bernard de Saint-Affrique has been appointed to the Board as a Non-Executive Director and member of the Audit and Nomination Committees, with effect from 1 January 2021.


Antoine is currently Chief Executive Officer of the Barry Callebaut Group, the world's leading manufacturer of chocolate and cocoa products, which is listed on the Swiss Stock Exchange (SIX).  Prior to joining Barry Callebaut in 2015, Antoine held several senior roles at Unilever plc, latterly as President of the Foods division and member of the Executive Committee.  From 2008 to March 2020, Antoine served as Non-Executive director of Essilor International, the world's leading ophthalmic optics company which, prior to its merger with Luxottica Group SpA, was listed on Euronext Paris and included in the CAC 40 index. 


Gerry Murphy, Chairman, said: "Antoine's international business experience, strong understanding of consumers and focus on sustainability will be hugely valuable to Burberry.  We are delighted that he has accepted our invitation to join the Burberry Board".


The Company confirms there is no further information to be disclosed pursuant to LR 9.6.13.


23 November 2020




Investors and analysts

Julian Easthope

VP, Investor Relations

020 3367 4458



Andrew Roberts

VP, Corporate Relations

020 3367 3764


This announcement does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any Burberry Group plc shares, in the UK, or in the US, or under the US Securities Act 1933 or in any other jurisdiction.

Burberry is listed on the London Stock Exchange (BRBY.L) and is a constituent of the FTSE 100 index. ADR symbol OTC:BURBY. 

BURBERRY, the Equestrian Knight Device, the Burberry Check and the Thomas Burberry Monogram and Print are trademarks belonging to Burberry.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.